{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:18:23Z","timestamp":1768418303825,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Major New Drugs Innovation and Development","award":["2012ZX09101201"],"award-info":[{"award-number":["2012ZX09101201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12906-018-2329-z","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T14:24:28Z","timestamp":1539699868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Post-marketing safety surveillance and re-evaluation of Xueshuantong injection"],"prefix":"10.1186","volume":"18","author":[{"given":"Chunxiao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"2329_CR1","unstructured":"National Pharmacopoeia Committee, Chinese Pharmacopoeia. Part 1. Beijing: Chemical Industry Press; 2005: Appendix 13."},{"key":"2329_CR2","volume-title":"Clinical application guide of TCM injections, People\u2019s health publishing house","author":"D-Q Ren","year":"2011","unstructured":"Ren D-Q, Zhang B-L. Clinical application guide of TCM injections, People\u2019s health publishing house. China: Beijing; 2011."},{"key":"2329_CR3","doi-asserted-by":"crossref","unstructured":"Li B, Wang Y, Lu J, et al. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial. Trials. 2015, 9;16:561.","DOI":"10.1186\/s13063-015-1076-4"},{"issue":"6","key":"2329_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1142\/S0192415X14500827","volume":"42","author":"Y Liu","year":"2014","unstructured":"Liu Y, Huang Y, Zhao C, et al. Salvia miltiorrhiza injection on pulmonary heart disease: a systematic review and meta-analysis. Am J Chin Med. 2014;42(6):1315\u201331.","journal-title":"Am J Chin Med."},{"key":"2329_CR5","doi-asserted-by":"crossref","unstructured":"Yang H, Zhang W, Huang C, et al. A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection. BMC Complement Altern Med. 2014, 4;14:430.","DOI":"10.1186\/1472-6882-14-430"},{"issue":"1","key":"2329_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1142\/S0192415X14500037","volume":"42","author":"J Luo","year":"2014","unstructured":"Luo J, Shang Q, Han M, et al. Traditional Chinese medicine injection for angina pectoris: an overview of systematic reviews. Am J Chin Med. 2014;42(1):37\u201359.","journal-title":"Am J Chin Med"},{"issue":"5","key":"2329_CR7","doi-asserted-by":"publisher","first-page":"e19604","DOI":"10.1371\/journal.pone.0019604","volume":"6","author":"Shufei Fu","year":"2011","unstructured":"Fu S, Zhang J, Menniti-Ippolito F, et al. Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review. PloS One. 2011, 6;6(5): 19604.","journal-title":"PLoS ONE"},{"issue":"2","key":"2329_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1517\/14740338.2015.985647","volume":"14","author":"XJ Guo","year":"2015","unstructured":"Guo XJ, Ye XF, Wang XX, et al. Reporting patterns of adverse drug reactions over recent years in China: analysis from publications. Expert Opin Drug Saf. 2015;14(2):191\u20138.","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"2329_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s11655-013-1502-y","volume":"19","author":"X Liao","year":"2013","unstructured":"Liao X, Robinson N. Methodological approaches to developing and establishing the body of evidence on post-marketing Chinese medicine safety. Chin J Integr Med. 2013;19(7):494\u20137.","journal-title":"Chin J Integr Med"},{"issue":"2","key":"2329_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1756-5391.2010.01073.x","volume":"3","author":"L Wang","year":"2010","unstructured":"Wang L, Yuan Q, Marshall G, et al. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on National Essential medicines list (2004 edition) of China: an overview on published literatures. J Evid Based Med. 2010;3(2):95\u2013104.","journal-title":"J Evid Based Med"},{"key":"2329_CR11","first-page":"134685","volume":"2015","author":"XM Wang","year":"2015","unstructured":"Wang XM, Wang SX, Wang JX, et al. Neuroprotective effect of xueshuantong for injection (lyophilized) in transient and permanent rat cerebral ischemia model. Evid Based Complement Alternat Med. 2015;2015:134685.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2329_CR12","first-page":"1","volume":"36","author":"FJ Wang","year":"2017","unstructured":"Wang FJ, Wang SX, Chai LJ, et al. Xueshuantong injection (lyophilized) combined with salvianolate lyophilized injection protects against focal cerebral ischemia\/reperfusion injury in rats through attenuation of oxidative stress. Acta Pharmacol Sin. 2017;36:1\u201314.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"2329_CR13","first-page":"743","volume":"41","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Shi C, Huang P. Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection. Zhongguo Zhong Yao Za Zhi. 2016;41(4):743\u20137.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"18","key":"2329_CR14","first-page":"2689","volume":"37","author":"JJ Jiang","year":"2012","unstructured":"Jiang JJ, Xie YM. Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections. Zhongguo Zhong Yao Za Zhi. 2012;37(18):2689\u201391.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"20","key":"2329_CR15","first-page":"2783","volume":"36","author":"X Li","year":"2011","unstructured":"Li X, Tang J, Meng F, et al. Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital. Zhongguo Zhong Yao Za Zhi. 2011;36(20):2783\u20135.","journal-title":"Zhongguo Zhong Yao Za Zhi."},{"key":"2329_CR16","first-page":"610846","volume":"2015","author":"XL Li","year":"2015","unstructured":"Li XL, Tang JF, Li WX, et al. Postmarketing safety surveillance and reevaluation of Danhong injection: clinical study of 30888 cases. Evid Based Complement Alternat Med. 2015;2015:610846.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2329_CR17","volume-title":"The key technologies of clinical re-evaluation of post-marketing traditional Chinese medicine, People\u2019s medical publishing house, Beijing, China","author":"Y-Y Wang","year":"2011","unstructured":"Y.-Y. Wang, A.-P. Lv, and Y.-M. Xie. The key technologies of clinical re-evaluation of post-marketing traditional Chinese medicine, People\u2019s medical publishing house, Beijing, China,2011."},{"key":"2329_CR18","doi-asserted-by":"publisher","first-page":"836051","DOI":"10.5402\/2011\/836051","volume":"2011","author":"E-W Baars","year":"2011","unstructured":"Baars E-W, Jong M, Nierop AF, et al. Savelkoul, \u201cCitrus\/cydonia compositum subcutaneous injections versus nasal spray for seasonal allergic rhinitis: a randomized controlled trial on efficacy and safety,\u201d. ISRN Allergy. 2011;2011:836051.","journal-title":"ISRN Allergy"},{"issue":"25","key":"2329_CR19","first-page":"715","volume":"11","author":"GF He","year":"2016","unstructured":"He GF, Dou WM. Zeng retrospective analysis on 697 cases of adverse drug reaction of Xueshuantong preparations. Chin J Pharmacoepidemiol. 2016;11(25):715\u20138.","journal-title":"Chin J Pharmacoepidemiol"},{"issue":"30","key":"2329_CR20","first-page":"139","volume":"01","author":"HC Li","year":"2014","unstructured":"Li HC, Wu QY, Fu JT, et al. Study on screening method of allergenic ingredients of TCM injections. Pharmacol Clin Chin Mater Med. 2014;01(30):139\u201341.","journal-title":"Pharmacol Clin Chin Mater Med"},{"key":"2329_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.aca.2017.11.069","volume":"1003","author":"Wu W. Feng","year":"2018","unstructured":"Feng WW, Zhang Y, Tang JF, et al. Combination of chemical fingerprinting with bioassay, a preferable approach for quality control of safflower injection. Anal Chim Acta. 2018,20;1003:56\u201363.","journal-title":"Analytica Chimica Acta"},{"issue":"20","key":"2329_CR22","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1007\/s00216-014-7918-1","volume":"406","author":"L Zhang","year":"2014","unstructured":"Zhang L, Ma L, Feng W, et al. Quality fluctuation detection of an herbal injection based on biological fingerprint combined with chemical fingerprint. Anal Bioanal Chem. 2014;406(20):5009\u201318.","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"2329_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jpba.2011.05.006","volume":"56","author":"Y Ren","year":"2011","unstructured":"Ren Y, Zhang P, Yan D, et al. A strategy for the detection of quality fluctuation of a Chinese herbal injection based on chemical fingerprinting combined with biological fingerprinting. J Pharm Biomed Anal. 2011;56(2):436\u201342.","journal-title":"J Pharm Biomed Anal"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2329-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-018-2329-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2329-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T23:05:56Z","timestamp":1571180756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-018-2329-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2329"],"URL":"https:\/\/doi.org\/10.1186\/s12906-018-2329-z","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was an observational study. No medical intervention was conducted on the observed objects. The experiment protocol was approved by the Ethical Committee of the First Affiliated Hospital of Henan University of TCM (Approval number 2014HL~\u2009053). In addition, this protocol has international registration in China clinical trial registration center (ChiCTR~OPC~\u200914,005,718). Written informed consents were obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There was no individual person\u2019s data in this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"277"}}